Tagala, Pablito L.

HRN: 23-01-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/19/2023
05/25/2023
IV
2.25g
Q8H
Community Acquired Pneumonia - Moderate Risk

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines